IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting
This study has been completed.
Sponsor:
Duke University
Collaborator:
Centers for Disease Control and Prevention
Information provided by (Responsible Party):
Duke University
ClinicalTrials.gov Identifier:
NCT00828555
First received: January 22, 2009
Last updated: October 15, 2012
Last verified: September 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
PURPOSE To develop, implement, and evaluate the effectiveness of a program designed to assist community Ob/Gyns in vaccinating adolescent and adult women against vaccine-preventable diseases.
SPECIFIC AIMS
-
Determine the feasibility of implementing a successful vaccination program for adolescent and adult women in Ob/Gyn offices by direct assessment of medical personnel & office staff on their:
- Attitudes towards vaccination of women against preventable diseases
- Perceived barriers to implementing a program to vaccinate women in their offices
- Ideas on how to overcome barriers to successful program implementation
- Current vaccination practices and office-specific administrative processes
- Design & implement a program for Ob/Gyns to vaccinate women against human papillomavirus, influenza, & pertussis
-
Determine the effectiveness of the vaccination program based on
- Pre- and post-program vaccination rates
- Program satisfaction amongst Ob/Gyn providers and office staff
- Willingness to continue and possibly extend the program to additional vaccines
- Quantify the level of support and resources needed to develop and implement the vaccination program
| Condition | Intervention |
|---|---|
| Influenza Vaccine Papillomavirus Infection Pertussis | Other: Vaccination Program |
| Study Type: | Observational |
| Official Title: | Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting |
Resource links provided by NLM:
Further study details as provided by Duke University:
Primary Outcome Measures:
- Implementation and measurement of a health services intervention in community or private Ob/Gyn practices to improve the delivery of standard clinical care to vaccinate women against human papillomavirus, influenza, & pertussis. [ Time Frame: Full-scale program implementation will cover a 12 month period, tentatively planned to begin in April 2009. ]
| Enrollment: | 3988 |
| Study Start Date: | November 2008 |
| Study Completion Date: | February 2012 |
| Primary Completion Date: | April 2009 (Final data collection date for primary outcome measure) |
Intervention Details:
-
Other: Vaccination Program
Design & implement a program for Ob/Gyns to vaccinate women against human papillomavirus, influenza, & pertussis
Eligibility| Ages Eligible for Study: | 12 Years to 26 Years (Child, Adult) |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
Population Groups:
Adults
Minors
Patients
Pregnant Women
Fetuses
Criteria
Inclusion Criteria:
- 4-5 community Ob/Gyn practices
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00828555
Please refer to this study by its ClinicalTrials.gov identifier: NCT00828555
Locations
| United States, North Carolina | |
| Westside OBGYN | |
| Burlington, North Carolina, United States | |
| DWHA | |
| Durham, North Carolina, United States, 27707 | |
| Atrium OBGYN | |
| Raleigh, North Carolina, United States | |
| Blue Ridge OBGYN | |
| Raleigh, North Carolina, United States | |
Sponsors and Collaborators
Duke University
Centers for Disease Control and Prevention
Investigators
| Principal Investigator: | Geeta Swamy, MD | Duke University |
More Information
| Responsible Party: | Duke University |
| ClinicalTrials.gov Identifier: | NCT00828555 History of Changes |
| Other Study ID Numbers: |
Pro00011038 |
| Study First Received: | January 22, 2009 |
| Last Updated: | October 15, 2012 |
Keywords provided by Duke University:
|
HPV vaccine Tdap vaccine |
Additional relevant MeSH terms:
|
Papillomavirus Infections DNA Virus Infections Virus Diseases Tumor Virus Infections |
Vaccines Immunologic Factors Physiological Effects of Drugs |
ClinicalTrials.gov processed this record on September 20, 2017